Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2003
08/13/2003EP1334983A2 Inhibitory, monoclonal antibody against the protease which activates clotting factor VII
08/13/2003EP1334982A2 Solubilized complement receptor type 1 in crystal form
08/13/2003EP1334981A2 Method for purifying keratinocyte growth factors
08/13/2003EP1334980A1 Multimerized highly functional antifreeze protein
08/13/2003EP1334730A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/13/2003EP1334727A2 Method for obtaining antigenic structures enhancing specific cross reactivity
08/13/2003EP1334201A2 Dna expression vectors
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334193A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/13/2003EP1334192A2 Cystoskeleton-associated proteins
08/13/2003EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof
08/13/2003EP1334185A2 Method for producing proteins by electroporation
08/13/2003EP1334183A2 NOVEL SOLUBLE ENDOPROTEASES FOR THE i IN VITRO /i PROCESSING OF RECOMBINANT PROTEINS
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334131A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334123A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
08/13/2003EP1334122A2 Nucleic acids encoding stichodactylidae chromoproteins
08/13/2003EP1334120A2 Modified clostridial neurotoxins with altered biological persistence
08/13/2003EP1333860A1 Antibodies to the propeptide of candida albicans and methods of use
08/13/2003EP1098665B9 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
08/13/2003EP0859629B1 Phosphorylated recombinant human beta casein for inhibition of attachment of h. influenzae to human cells
08/13/2003EP0695361B1 Expression of heterologous genes according to a targeted expression profile
08/13/2003EP0669980B1 Method of controlling polypeptide production in bacteria
08/13/2003EP0667959B1 Methods for identifying inhibitors of the production of beta-amyloid peptide
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0575491B1 Genetically engineered vaccine strain
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003CN1436246A Method for preparing physiologically active IL-18 polypeptide
08/13/2003CN1436239A Novel enzyme gene and its expression product
08/13/2003CN1436238A Anti-listeria bacteriocin
08/13/2003CN1436237A Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/13/2003CN1436236A Gasci基因 Gasci gene
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1435486A Human composite alpha-interferon engineered gene, its expression and production thereof
08/13/2003CN1435431A Polypeptides matter, method for preparing same and use thereof
08/13/2003CN1435426A Recombinant human dyad stem cell factor and preparing thereof
08/13/2003CN1117873C Process for preparation of protein oligopeptide
08/13/2003CN1117863C Surface anchoring vector and system for foreign proteins thereof
08/13/2003CN1117859C Method of cultivating bacteria producing proteins that are expressed in temp. regulated manner
08/13/2003CN1117764C Gene engineering immune toxin of anti-carcinoma of bladder and its prodn. process
08/13/2003CN1117763C Anti-alphaV-integrin monoclonal antibody
08/12/2003US6605706 Gene expressing polypeptide in prokaryotic cells; harvesting, solubilizing cells in buffer with chaotropic and reducing agents; dilution
08/12/2003US6605705 Prostaglandin D synthase-specific monoclonal antibody
08/12/2003US6605697 Modified E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of a said peptide and a heterologous protein
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605590 Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids
08/12/2003US6605465 Methods for avoiding maternal immunity
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605462 Bacillus thuringiensis isolates active against weevils
08/12/2003US6605456 Nucleic acids encoding IKR-2, a protein kinase related to the I kappa B kinases
08/12/2003US6605449 Saturation mutagenesis to produce progenitor polynucleotide library
08/12/2003US6605442 Methods of testing drugs or agents that modulate the activity of receptor recognition factors
08/12/2003US6605437 Screening methods for compounds useful for the treatment of body weight disorders, including obesity
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6605277 Conformation-specific anti-von Willebrand factor antibodies
08/12/2003US6605276 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
08/12/2003US6605272 Methods of using zalpha11 ligand
08/12/2003CA2223155C Secretion leader trap cloning method
08/12/2003CA2216425C Tetanus toxin functional fragment antigen and tetanus vaccine
08/12/2003CA2116888C Human anti-tnf antibodies
08/07/2003WO2003065003A2 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
08/07/2003WO2003064672A1 Cell extract for cell-free protein synthesis and process for producing the same
08/07/2003WO2003064671A1 Germ extract for cell-free protein synthesis and process for producing the same
08/07/2003WO2003064659A1 Methods and compositions for optimizing recombinant expression
08/07/2003WO2003064656A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
08/07/2003WO2003064649A1 Promoter expressing foreign gene in root and shoot apex
08/07/2003WO2003064630A2 Cell culture medium
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064608A2 Surface based translation system
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064597A2 Aggrecanase molecules
08/07/2003WO2003064474A1 Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same
08/07/2003WO2003064473A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064469A2 Regulation of human hematopoietin receptor-like protein
08/07/2003WO2003063783A2 Multiple virus replicon culture systems
08/07/2003WO2003063772A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003WO2003063608A1 A process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
08/07/2003WO2003046556A3 Globin biopolymer markers indicative of insulin resistance
08/07/2003WO2003042366A3 A novel saitohin gene and uses of same
08/07/2003WO2003018797A3 Method and device for integrated protein expression, purification and detection
08/07/2003WO2003006667A3 Method for preparing lipid ii and use of the lipid ii thus obtained
08/07/2003WO2002096948A3 Engineered tetravalent antibodies and methods of use
08/07/2003WO2002083069A3 Recombinant proteins of orientia tsutsugamushi
08/07/2003WO2002077179A3 Leinamycin biosynthesis gene cluster and its components and their uses
08/07/2003WO2002068476A3 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
08/07/2003WO2002057457A3 Human proteins 55562 and 21617, and methods of use thereof
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002020848A3 Gene and sequence variation associated with cancer
08/07/2003WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
08/07/2003WO2002004015A9 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
08/07/2003US20030150010 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
08/07/2003US20030149996 Method for producing polyclonal and monoclonal antibodies
08/07/2003US20030149261 2'/3'-O-acetyl-ADP-ribose is produced by reacting Sir2 enzymes with acetylated peptide substrate (p53 genes) and NAD+; anticancer agents
1 ... 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 ... 1125